T. Rowe Price Associates’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Buy |
166,367
+43,267
| +35% | +$61.6K | ﹤0.01% | 2632 |
|
|
2025
Q1 | $189K | Hold |
123,100
| – | – | ﹤0.01% | 2663 |
|
|
2024
Q4 | $306K | Sell |
123,100
-16,300
| -12% | -$40.5K | ﹤0.01% | 2491 |
|
|
2024
Q3 | $161K | Hold |
139,400
| – | – | ﹤0.01% | 2721 |
|
|
2024
Q2 | $154K | Buy |
139,400
+29,633
| +27% | +$32.7K | ﹤0.01% | 2661 |
|
|
2024
Q1 | $137K | Buy |
109,767
+1,252
| +1% | +$1.56K | ﹤0.01% | 2716 |
|
|
2023
Q4 | $114K | Sell |
108,515
-21,372
| -16% | -$22.5K | ﹤0.01% | 2691 |
|
|
2023
Q3 | $890K | Buy |
129,887
+80,907
| +165% | +$554K | ﹤0.01% | 1847 |
|
|
2023
Q2 | $508K | Buy |
48,980
+1,512
| +3% | +$15.7K | ﹤0.01% | 2112 |
|
|
2023
Q1 | $385K | Buy |
47,468
+756
| +2% | +$6.13K | ﹤0.01% | 2221 |
|
|
2022
Q4 | $736K | Sell |
46,712
-394
| -0.8% | -$6.21K | ﹤0.01% | 1942 |
|
|
2022
Q3 | $742K | Buy |
47,106
+9,077
| +24% | +$143K | ﹤0.01% | 1917 |
|
|
2022
Q2 | $531K | Buy |
38,029
+6,460
| +20% | +$90.2K | ﹤0.01% | 2195 |
|
|
2022
Q1 | $544K | Sell |
31,569
-774
| -2% | -$13.3K | ﹤0.01% | 2291 |
|
|
2021
Q4 | $470K | Sell |
32,343
-399
| -1% | -$5.8K | ﹤0.01% | 2407 |
|
|
2021
Q3 | $589K | Sell |
32,742
-9,235
| -22% | -$166K | ﹤0.01% | 2296 |
|
|
2021
Q2 | $737K | Buy |
41,977
+12,857
| +44% | +$226K | ﹤0.01% | 2194 |
|
|
2021
Q1 | $734K | Buy |
+29,120
| New | +$734K | ﹤0.01% | 2185 |
|
|
2019
Q4 | – | Sell |
-31,393
| Closed | -$34K | – | 2517 |
|
|
2019
Q3 | $34K | Buy |
31,393
+147
| +0.5% | +$159 | ﹤0.01% | 2489 |
|
|
2019
Q2 | $68K | Buy |
31,246
+20,800
| +199% | +$45.3K | ﹤0.01% | 2494 |
|
|
2019
Q1 | $63K | Buy |
+10,446
| New | +$63K | ﹤0.01% | 2485 |
|
|
2017
Q4 | – | Sell |
-340,343
| Closed | -$8.78M | – | 2545 |
|
|
2017
Q3 | $8.78M | Sell |
340,343
-67,400
| -17% | -$1.74M | ﹤0.01% | 1339 |
|
|
2017
Q2 | $11.1M | Buy |
407,743
+63,426
| +18% | +$1.72M | ﹤0.01% | 1304 |
|
|
2017
Q1 | $10.3M | Buy |
+344,317
| New | +$10.3M | ﹤0.01% | 1326 |
|